Reported 17,476 shares, up 16,467 (1632.0%) from the prior quarter.
Reported value 1318.7%; share count 1632.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 206000 |
| 2022-03-31 | 25000 |
| 2022-06-30 | 25000 |
| 2022-09-30 | 32000 |
| 2022-12-31 | 22165 |
| 2023-03-31 | 27014 |
| 2023-06-30 | 24740 |
| 2023-09-30 | 15985 |
| 2023-12-31 | 0 |
| 2023-12-31 | 9660 |
| 2024-03-31 | 19765 |
| 2024-06-30 | 14834 |
| 2024-09-30 | 11395 |
| 2024-12-31 | 15824 |
| 2025-03-31 | 12921 |
| 2025-06-30 | 11190 |
| 2025-09-30 | 17419 |
| 2025-12-31 | 39071 |
| 2026-03-31 | 45807 |
| 2026-06-30 | 37989 |
| 2026-09-30 | 538960 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 17,476 | +16,467 (1632.0%) | < 0.01% | $538,960 | 2026-11-13 | |
| Q2 2026 | Reduced | 1,009 | -146 (-12.6%) | < 0.01% | $37,989 | 2026-08-13 | |
| Q1 2026 | Added | 1,155 | +178 (18.2%) | < 0.01% | $45,807 | 2026-05-15 | |
| Q4 2025 | Added | 977 | +231 (31.0%) | < 0.01% | $39,071 | 2026-02-13 | |
| Q3 2025 | Unchanged | 746 | 0 (0.0%) | < 0.01% | $17,419 | 2025-11-14 | |
| Q2 2025 | Unchanged | 746 | 0 (0.0%) | < 0.01% | $11,190 | 2025-08-15 | |
| Q1 2025 | Reduced | 746 | -400 (-34.9%) | < 0.01% | $12,921 | 2025-05-15 | |
| Q4 2024 | Added | 1,146 | +306 (36.4%) | < 0.01% | $15,824 | 2025-02-14 | |
| Q3 2024 | Unchanged | 840 | 0 (0.0%) | < 0.01% | $11,395 | 2024-11-14 | |
| Q2 2024 | Unchanged | 840 | 0 (0.0%) | < 0.01% | $14,834 | 2024-08-14 | |
| Q1 2024 | Unchanged | 840 | 0 (0.0%) | < 0.01% | $19,765 | 2024-05-15 | |
| Q4 2023 | New | 840 | +840 (0.0%) | < 0.01% | $9,660 | 2024-02-13 | |
| Q4 2023 | Reduced | 0 | -33,442 (-100.0%) | 0 | $0 | 2024-02-13 | |
| Q3 2023 | Unchanged | 33,442 | 0 (0.0%) | < 0.01% | $15,985 | 2023-11-15 | |
| Q2 2023 | Unchanged | 33,442 | 0 (0.0%) | < 0.01% | $24,740 | 2023-08-14 | |
| Q1 2023 | Unchanged | 33,442 | 0 (0.0%) | < 0.01% | $27,014 | 2023-05-15 | |
| Q4 2022 | Reduced | 33,442 | -1 (0.0%) | < 0.01% | $22,165 | 2023-02-14 | |
| Q3 2022 | Unchanged | 33,443 | 0 (0.0%) | < 0.01% | $32,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 33,443 | -1,723 (-4.9%) | < 0.01% | $25,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 35,166 | -172,087 (-83.0%) | < 0.01% | $25,000 | 2022-05-13 | |
| Q4 2021 | Added | 207,253 | +128,358 (162.7%) | < 0.01% | $206,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
50 managers reported VTV THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Samsara BioCapital LLC | Added | 354,730 | +56,234 | 1.04% | $10,939,873 | 12 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 342,481 | +72,607 | < 0.01% | $10,562,114 | 6 qtrs |
| FMR LLC | Unchanged | 260,391 | 0 | < 0.01% | $8,030,458 | 11 qtrs |
| Siren L L C | Unchanged | 163,000 | 0 | 0.12% | $5,026,920 | 5 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 148,314 | 0 | 0.02% | $4,574,004 | 11 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 81,740 | -12,723 | < 0.01% | $2,520,862 | 3 qtrs |
| Trails Edge Capital Partners LP | Reduced | 76,989 | -8,203 | 0.34% | $2,374,341 | 4 qtrs |
| Aisling Capital Management LP | Added | 58,775 | +8,775 | 0.61% | $1,812,621 | 2 qtrs |
| TWO SIGMA INVESTMENTS LP | Added | 47,654 | +36,168 | < 0.01% | $1,469,649 | 2 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 24,350 | -8,120 | < 0.01% | $751,697 | 9 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- CL A NEW
Voting authority reported
- Sole
- 16,730
- Shared
- 0
- None
- 746
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.